MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 30.68 million. The enterprise value is 120.02 million.
| Market Cap | 30.68M |
| Enterprise Value | 120.02M |
Important Dates
The last earnings date was Wednesday, March 11, 2026.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 397.72 million shares outstanding. The number of shares has increased by 2.90% in one year.
| Current Share Class | 397.72M |
| Shares Outstanding | 397.72M |
| Shares Change (YoY) | +2.90% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 10.70% |
| Owned by Institutions (%) | 0.24% |
| Float | 331.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | 4.70 |
| P/OCF Ratio | 3.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.61, with an EV/FCF ratio of 18.39.
| EV / Earnings | -8.29 |
| EV / Sales | 0.75 |
| EV / EBITDA | 10.61 |
| EV / EBIT | n/a |
| EV / FCF | 18.39 |
Financial Position
The company has a current ratio of 1.00, with a Debt / Equity ratio of 1.32.
| Current Ratio | 1.00 |
| Quick Ratio | 0.30 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 7.55 |
| Debt / FCF | 13.08 |
| Interest Coverage | -0.31 |
Financial Efficiency
Return on equity (ROE) is -20.13% and return on invested capital (ROIC) is -1.61%.
| Return on Equity (ROE) | -20.13% |
| Return on Assets (ROA) | -0.71% |
| Return on Invested Capital (ROIC) | -1.61% |
| Return on Capital Employed (ROCE) | -1.63% |
| Weighted Average Cost of Capital (WACC) | 7.83% |
| Revenue Per Employee | 206,494 |
| Profits Per Employee | -18,713 |
| Employee Count | 832 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 2.91 |
Taxes
In the past 12 months, MariMed has paid 3.59 million in taxes.
| Income Tax | 3.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.95% in the last 52 weeks. The beta is 1.10, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -24.95% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 45.25 |
| Average Volume (20 Days) | 392,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, MariMed had revenue of 159.83 million and -14.48 million in losses. Loss per share was -0.04.
| Revenue | 159.83M |
| Gross Profit | 57.88M |
| Operating Income | -2.33M |
| Pretax Income | -10.86M |
| Net Income | -14.48M |
| EBITDA | 9.18M |
| EBIT | -2.33M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 8.88 million in cash and 85.36 million in debt, with a net cash position of -76.48 million or -0.19 per share.
| Cash & Cash Equivalents | 8.88M |
| Total Debt | 85.36M |
| Net Cash | -76.48M |
| Net Cash Per Share | -0.19 |
| Equity (Book Value) | 64.73M |
| Book Value Per Share | 0.13 |
| Working Capital | 223,000 |
Cash Flow
In the last 12 months, operating cash flow was 7.70 million and capital expenditures -1.17 million, giving a free cash flow of 6.53 million.
| Operating Cash Flow | 7.70M |
| Capital Expenditures | -1.17M |
| Free Cash Flow | 6.53M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 36.22%, with operating and profit margins of -1.46% and -9.06%.
| Gross Margin | 36.22% |
| Operating Margin | -1.46% |
| Pretax Margin | -6.80% |
| Profit Margin | -9.06% |
| EBITDA Margin | 5.74% |
| EBIT Margin | -1.46% |
| FCF Margin | 4.08% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.90% |
| Shareholder Yield | -2.90% |
| Earnings Yield | -47.21% |
| FCF Yield | 21.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.05 |
| Piotroski F-Score | 2 |